Skip to main content
Healthy Skeptic
search
Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts
  • search
Close Search

Commentary

 

Aug 31 2018

Exchange Premiums and Number of Insurers

By Kevin Roche Commentary No Comments
Seems obvious, but a Health Affairs study confirms that premiums on the insurance exchanges are higher when fewer plans participate.
Read More
Aug 30 2018

Medicare’s Payments to Long-term Care Hospitals

By Kevin Roche Commentary No Comments
Here is a shock, a government program, Medicare, that wastes taxpayer dollars by paying more for care in one setting than another, in this case long-term care hospitals.
Read More
Aug 29 2018

Evaluation of CMS’ Next Generation ACO Program

By Kevin Roche Commentary No Comments
CMS issues the first annual outside evaluation of the Next Generation ACO program, finding some modest savings.
Read More
Aug 28 2018

High-Deductible Health Plan Trends

By Kevin Roche Commentary No Comments
A study carried in Health Affairs discusses trends in high-deductible health plans.
Read More
Aug 27 2018

Cost-effectiveness of Cell and Gene Therapies

By Kevin Roche Commentary No Comments
The Alliance for Regenerative Medicine releases a sponsored study of the cost-effectiveness analysis of new cell and gene therapies.
Read More
Aug 24 2018

Cost Savings from Hospital Mergers

By Kevin Roche Commentary No Comments
Hospitals post underwhelming purchasing savings following acquisition activity, according to a new paper at NBER.
Read More
Aug 23 2018

Medicare Purchases of Brand-name Versus Generic Medications

By Kevin Roche Commentary No Comments
An analysis published in JAMA finds that Medicare is wasting about a billion dollars a year purchasing brand-name drugs.
Read More
Aug 22 2018

Service Use Variation In MA and FFS Medicare

By Kevin Roche Commentary No Comments
An analysis in Health Affairs compares hospital, home health and SNF use and variation in Medicare Advantage versus the fee-for-service version.
Read More
Aug 21 2018

Variation in Hospital Pricing

By Kevin Roche Commentary No Comments
A report from the Minnesota Department of Health reveals the variation in hospital pricing.
Read More
Aug 20 2018

McKinsey Report on MA Star Ratings

By Kevin Roche Commentary No Comments
McKinsey gives us its perspective on trends in Medicare Advantage star ratings.
Read More
  • « Previous
  • 1
  • …
  • 397
  • 398
  • 399
  • 400
  • 401
  • …
  • 641
  • Next »

✅ Receive notifications of new posts by email.

About this Blog

Kevin RocheThe Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.

Healthy Skeptic Podcast

Research

This is an outstanding report on total global drug spending and trends, with projections out to 2025.  It helps you understand this important area of health care, which does much...
June 1, 2021
The Office of the Actuary annual report on national health spending, covering 2018.
December 7, 2019
2019 Kaiser Family Foundation Employer Health Benefits Report
October 1, 2019
MedPAC 2019 Report to Congress
June 18, 2019

Headlines

IKS Health, a British company with a US subsidiary that offers “care enablement” and mentions AI, of course,  is buying TruBridge for $557 million.  TruBridge offers revenue cycle management and...
April 30, 2026
Innovacer, which basically collects data on a patient from multiple sources and aggregates it, raised an astounding $275 million in new capital, supposedly at a valuation of almost $3.5 billion....
April 22, 2026
A company called Whoop raised a ridiculous $575 million in new capital at a supposed $10 billion valuation.  The press release was released on April 1, so I would like...
April 5, 2026
Big deals continue in health care financings.  eMed, which manages weight loss medications for employers, raises a hefty $200 million, giving it a valuation of $2 billion, which seems crazy....
March 31, 2026

Tags

Access (89) ACO (165) Care Management (268) Chronic Disease (216) Comparative Effectiveness (81) Consumer Directed Health (71) Consumers (514) Devices (168) Disease Management (149) Drugs (605) EHRs (145) Elder Care (149) End-of-Life Care (97) FDA (85) Financings (1844) Genomics (80) Government (357) Health Care Costs (1428) Health Care Quality (616) Health Care Reform (1227) Health Insurance (1116) Health Insurance Exchange (162) HIT (478) HomeCare (76) Hospital (490) Hospital Readmissions (79) Legislation (78) M&A (1723) Malpractice (84) Meaningful Use (105) Medicaid (334) Medical Care (346) Medicare (607) Medicare Advantage (80) Mobile (89) Pay For Performance (92) Pharmaceutical (211) Physicians (569) Providers (252) Regulation (72) Repealing Reform (133) Telehealth (79) Telemedicine (325) Wellness and Prevention (316) Workplace (117)

About This Blog

The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry through Roche Consulting, LLC. Mr. Roche is available to assist health care companies through consulting arrangements and may be reached at khroche@healthy-skeptic.com. © Roche Consulting, LLC. Terms of Use.

Categories

  • Commentary
  • Headlines
  • Research

Useful Links

  • Health Affairs
  • Congressional Budget Office

RSS Feed

RSS feed

© 2026 Healthy Skeptic.

  • twitter
  • facebook
  • linkedin
Close Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts